Preface on Breakthroughs in the Treatment of Advanced Lung Cancer: Making Progress Through Innovation1
Lung cancer: biology and technology foster therapeutic innovation
Annals of Translational Medicine
2018;
6
(8)
:137
(April 2018)
Review Article on Breakthroughs in the Treatment of Advanced Lung Cancer: Making Progress Through Innovation1
The emerging treatment landscape of advanced non-small cell lung cancer
Annals of Translational Medicine
2018;
6
(8)
:138
(April 2018)
Novel chemotherapy regimens for advanced lung cancer: have we reached a plateau?
Annals of Translational Medicine
2018;
6
(8)
:139
(April 2018)
Making progress in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer by surpassing resistance: third-generation EGFR tyrosine kinase inhibitors (EGFR-TKIs)
Annals of Translational Medicine
2018;
6
(8)
:140
(April 2018)
Treating ALK-positive non-small cell lung cancer
Annals of Translational Medicine
2018;
6
(8)
:141
(April 2018)
Beyond EGFR and ALK: targeting rare mutations in advanced non-small cell lung cancer
Annals of Translational Medicine
2018;
6
(8)
:142
(April 2018)
Breakthroughs in the treatment of advanced squamous-cell NSCLC: not the neglected sibling anymore?
Annals of Translational Medicine
2018;
6
(8)
:143
(April 2018)
Implementation of immunotherapy in the treatment of advanced non-small cell lung cancer (NSCLC)
Annals of Translational Medicine
2018;
6
(8)
:144
(April 2018)
Advanced small cell lung cancer (SCLC): new challenges and new expectations
Annals of Translational Medicine
2018;
6
(8)
:145
(April 2018)
Advances on systemic treatment for lung neuroendocrine neoplasms
Annals of Translational Medicine
2018;
6
(8)
:146
(April 2018)
Original Article
Effects of atypical antipsychotic drugs on QT interval in patients with mental disorders
Annals of Translational Medicine
2018;
6
(8)
:147
(April 2018)
Alcohol use disorders before and after bariatric surgery: a systematic review and meta-analysis
Annals of Translational Medicine
2018;
6
(8)
:148
(April 2018)
Targets without tolerances: improper evaluation of medical personnel
Annals of Translational Medicine
2018;
6
(8)
:149
(April 2018)
A technique of hand digit reconstruction using scarred and deformed donor segments
Annals of Translational Medicine
2018;
6
(8)
:150
(April 2018)
The practical benefit of Phadiatop test as the first-line in vitro allergen-specific immunoglobulin E (sIgE) screening of aeroallergens among Chinese asthmatics: a validation study
Annals of Translational Medicine
2018;
6
(8)
:151
(April 2018)
Rosiglitazone inhibits PM2.5-induced cytotoxicity in human lung epithelial A549 cells
Annals of Translational Medicine
2018;
6
(8)
:152
(April 2018)
Traditional Chinese medicine Qiliqiangxin attenuates phenylephrine-induced cardiac hypertrophy via upregulating PPARγ and PGC-1α
Annals of Translational Medicine
2018;
6
(8)
:153
(April 2018)
Review Article
Aminoquinoline antimalarial therapy in dermatomyositis—are we missing opportunities with respect to comorbidities and modulation of extracutaneous disease activity?
Annals of Translational Medicine
2018;
6
(8)
:154
(April 2018)
Immune checkpoint inhibitors and radiotherapy—concept and review of current literature
Annals of Translational Medicine
2018;
6
(8)
:155
(April 2018)
Case Report
Abnormal chest X-ray leading to diagnosis of partial anomalous pulmonary venous connection
Annals of Translational Medicine
2018;
6
(8)
:156
(April 2018)
Perspective
The search for gene-gene interactions in genome-wide association studies: challenges in abundance of methods, practical considerations, and biological interpretation
Annals of Translational Medicine
2018;
6
(8)
:157
(April 2018)
Disclosure:
1. The series “Breakthroughs in the Treatment of Advanced Lung Cancer: Making Progress Through Innovation” was commissioned by the editorial office, Annals of Translational Medicine without any sponsorship or funding. Giannis Mountzios served as the unpaid Guest Editor for the series.
